Gilead Sciences (GILD) Raises Quarterly Dividend 2.8% to $0.73; 4.3% Yield

Go back to Gilead Sciences (GILD) Raises Quarterly Dividend 2.8% to $0.73; 4.3% Yield

Gilead Sciences (GILD) PT Lowered to $80 at Jefferies

February 2, 2022 8:15 AM EST

Jefferies analyst Michael Yee lowered the price target on Gilead Sciences (NASDAQ: GILD) to $80.00 (from $85.00) while maintaining a Buy rating.

The analyst commented, "GILD says it is "excited" to also now look at an interim OS along with PFS, so investor focus... More

BMO Capital Lowers PT on Gilead (GILD) to $75 Following Earnings, Reiterates Focus on TROPiCS-02 Data Readout

February 2, 2022 5:20 AM EST

BMO Capital analyst Evan David Seigerman lowered the price target on Gilead Sciences (NASDAQ: GILD) to $75.00 (from $85.00) while maintaining a Outperform rating, following Q4 earnings release.

The analyst quotes: "Starting 2022 with a whimper: soft '22 guide, 4Q EPS miss, and a... More

BMO Capital Lowers PT on Gilead (GILD) to $75 Following Earnings, Reiterates Focus on TROPiCS-02 Data Readout

February 2, 2022 5:20 AM EST

BMO Capital analyst Evan David Seigerman lowered the price target on Gilead Sciences (NASDAQ: GILD) to $75.00 (from $85.00) while maintaining a Outperform rating, following Q4 earnings release.

The analyst quotes: "Starting 2022 with a whimper: soft '22 guide, 4Q EPS miss, and a... More